{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T10:05:47Z","timestamp":1769076347020,"version":"3.49.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T00:00:00Z","timestamp":1604707200000},"content-version":"vor","delay-in-days":1620,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Institute of Health Carlos III","doi-asserted-by":"publisher","award":["RIC RD12\/0042\/0027"],"award-info":[{"award-number":["RIC RD12\/0042\/0027"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1194\/jlr.p061598","type":"journal-article","created":{"date-parts":[[2016,4,26]],"date-time":"2016-04-26T04:08:36Z","timestamp":1461643716000},"page":"1059-1073","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["ApoL1 levels in high density lipoprotein and cardiovascular event presentation in patients with familial hypercholesterolemia"],"prefix":"10.1016","volume":"57","author":[{"given":"Judit","family":"Cubedo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Padr\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Mata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Badimon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1194\/jlr.P061598_bib1","unstructured":"Goldstein, J. L., H. H. Hobbs, and M. S. Brown, . 2001. The metabolic and molecular basis of inherited disease. In Familial hypercholesterolemia. C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle, editors. McGraw-Hill, New York. 2863\u20132913."},{"key":"10.1194\/jlr.P061598_bib2","doi-asserted-by":"crossref","unstructured":"Wierzbicki, A. S., S. E. Humphries, R. Minhas, ; Guideline Development Group. 2008. Familial hypercholesterolaemia: summary of NICE guidance. Br. Med. J. 337: a1095.","DOI":"10.1136\/bmj.a1095"},{"key":"10.1194\/jlr.P061598_bib3","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1365-2796.2004.01405.x","article-title":"The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients","volume":"256","author":"Jansen","year":"2004","journal-title":"J. Intern. Med."},{"key":"10.1194\/jlr.P061598_bib4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.atherosclerosis.2013.12.020","article-title":"Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: a study of a cohort of 14,000 mutation carriers","volume":"233","author":"Besseling","year":"2014","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.P061598_bib5","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jacc.2014.01.063","article-title":"Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation","volume":"63","author":"Alonso","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1194\/jlr.P061598_bib6","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1161\/01.ATV.8.6.737","article-title":"High density lipoprotein cholesterol and mortality. The Framingham Heart Study","volume":"8","author":"Wilson","year":"1988","journal-title":"Arteriosclerosis."},{"key":"10.1194\/jlr.P061598_bib7","first-page":"455","article-title":"High density lipoprotein plasma fractions inhibit aortic fatty streaks in cholesterol-fed rabbits","volume":"60","author":"Badimon","year":"1989","journal-title":"Lab. Invest."},{"key":"10.1194\/jlr.P061598_bib8","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1172\/JCI114558","article-title":"Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit","volume":"85","author":"Badimon","year":"1990","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.P061598_bib9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.atherosclerosis.2011.10.006","article-title":"Recombinant HDL(Milano) exerts greater anti-inflammatory and plaque stabilizing properties than HDL(wild-type)","volume":"220","author":"Ibanez","year":"2012","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.P061598_bib10","doi-asserted-by":"crossref","unstructured":"Badim\u00f3n, J. J., C. G. Santos-Gallego, and L. Badim\u00f3n, . 2010. Importance of HDL cholesterol in atherothrombosis: how did we get here? Where are we going? [Article in Spanish] Rev. Esp. Cardiol. 63 (Suppl. 2): 20\u201335.","DOI":"10.1016\/S0300-8932(10)70150-0"},{"issue":"Suppl.","key":"10.1194\/jlr.P061598_bib11","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/0021-9150(96)05852-2","article-title":"High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport","volume":"124","author":"Assmann","year":"1996","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.P061598_bib12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/01.ATV.17.1.107","article-title":"Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men","volume":"17","author":"Goldbourt","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.P061598_bib13","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/eurheartj\/ehi186","article-title":"High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial","volume":"26","author":"Olsson","year":"2005","journal-title":"Eur. Heart J."},{"key":"10.1194\/jlr.P061598_bib14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1749-6632.2012.06480.x","article-title":"LDL-cholesterol versus HDL-cholesterol in the atherosclerotic plaque: inflammatory resolution versus thrombotic chaos","volume":"1254","author":"Badimon","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1194\/jlr.P061598_bib15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/CIRCRESAHA.114.300935","article-title":"High-density lipoprotein: vascular protective effects, dysfunction, and potential as therapeutic target","volume":"114","author":"L\u00fcscher","year":"2014","journal-title":"Circ. Res."},{"key":"10.1194\/jlr.P061598_bib16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/978-3-319-09665-0_10","article-title":"Dysfunctional HDL: from structure-function-relationships to biomarkers","volume":"224","author":"Riwanto","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1194\/jlr.P061598_bib17","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1093\/eurheartj\/ehs182","article-title":"Increasing high-density lipoprotein cholesterol by cholesteryl ester transfer protein-inhibition: a rocky road and lessons learned? The early demise of the dal-HEART programme","volume":"33","author":"Landmesser","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1194\/jlr.P061598_bib18","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.molmed.2011.05.013","article-title":"Biological activities of HDL subpopulations and their relevance to cardiovascular disease","volume":"17","author":"Camont","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1194\/jlr.P061598_bib19","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1161\/ATVBAHA.111.227181","article-title":"Atheroprotective reverse cholesterol transport pathway is defective in familial hypercholesterolemia","volume":"31","author":"Bellanger","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.P061598_bib20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.atherosclerosis.2012.02.024","article-title":"Differential proteomic distribution of TTR (pre-albumin) forms in serum and HDL of patients with high cardiovascular risk","volume":"222","author":"Cubedo","year":"2012","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.P061598_bib21","doi-asserted-by":"crossref","first-page":"25576","DOI":"10.1074\/jbc.272.41.25576","article-title":"Apolipoprotein L, a new human high density lipoprotein apolipoprotein expressed by the pancreas. Identification, cloning, characterization, and plasma distribution of apolipoprotein L","volume":"272","author":"Duchateau","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.P061598_bib22","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/ATVBAHA.109.186031","article-title":"Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function","volume":"29","author":"Davidson","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.P061598_bib23","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1101\/gr.085647.108","article-title":"The apolipoprotein L family of programmed cell death and immunity genes rapidly evolved in primates at discrete sites of host-pathogen interactions","volume":"19","author":"Smith","year":"2009","journal-title":"Genome Res."},{"key":"10.1194\/jlr.P061598_bib24","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0022-2275(20)31171-8","article-title":"Apolipoprotein L gene family: tissue-specific expression, splicing, promoter regions; discovery of a new gene","volume":"42","author":"Duchateau","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.P061598_bib25","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1006\/geno.2002.6729","article-title":"The apolipoprotein L gene cluster has emerged recently in evolution and is expressed in human vascular tissue","volume":"79","author":"Monajemi","year":"2002","journal-title":"Genomics."},{"key":"10.1194\/jlr.P061598_bib26","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s00018-006-6091-x","article-title":"The function of apolipoproteins L","volume":"63","author":"Vanhollebeke","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1194\/jlr.P061598_bib27","doi-asserted-by":"crossref","first-page":"11430","DOI":"10.1016\/S0021-9258(17)44242-6","article-title":"In vitro conversion of proapoprotein A-I to apoprotein A-I. Partial characterization of an extracellular enzyme activity","volume":"258","author":"Edelstein","year":"1983","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.P061598_bib28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0022-2275(20)34388-1","article-title":"Human apolipoprotein A-I isoprotein metabolism: proapoA-I conversion to mature apoA-I","volume":"26","author":"Bojanovski","year":"1985","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.P061598_bib29","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/CIRCRESAHA.114.302347","article-title":"Increased burden of cardiovascular disease in carriers of APOL1 genetic variants","volume":"114","author":"Ito","year":"2014","journal-title":"Circ. Res."},{"key":"10.1194\/jlr.P061598_bib30","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1053\/j.ackd.2014.06.005","article-title":"APOL1 kidney risk alleles: population genetics and disease associations","volume":"21","author":"Limou","year":"2014","journal-title":"Adv. Chronic Kidney Dis."},{"key":"10.1194\/jlr.P061598_bib31","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1111\/ajt.13223","article-title":"Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure","volume":"15","author":"Freedman","year":"2015","journal-title":"Am. J. Transplant."},{"key":"10.1194\/jlr.P061598_bib32","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1681\/ASN.2014101052","article-title":"Apolipoprotein L1-associated nephropathy and the future of renal diagnostics","volume":"26","author":"Larsen","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1194\/jlr.P061598_bib33","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1194\/jlr.M400304-JLR200","article-title":"Apolipoprotein L\u2013I is positively associated with hyperglycemia and plasma triglycerides in CAD patients with low HDL","volume":"46","author":"Albert","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.P061598_bib34","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1161\/CIRCRESAHA.114.303354","article-title":"Cardiovascular twist to the rapidly evolving apolipoprotein L1 story","volume":"114","author":"Farrall","year":"2014","journal-title":"Circ. Res."},{"key":"10.1194\/jlr.P061598_bib35","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1021\/pr100805h","article-title":"Proteomic signature of apolipoprotein J in the early phase of new-onset myocardial infarction","volume":"10","author":"Cubedo","year":"2011","journal-title":"J. Proteome Res."},{"key":"10.1194\/jlr.P061598_bib36","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.trsl.2014.03.008","article-title":"Glycoproteome of human apolipoprotein A-I: N- and O-glycosylated forms are increased in patients with acute myocardial infarction","volume":"164","author":"Cubedo","year":"2014","journal-title":"Transl. Res."},{"key":"10.1194\/jlr.P061598_bib37","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1194\/jlr.P057513","article-title":"A novel truncated form of apolipoprotein A-I transported by dense LDL is increased in diabetic patients","volume":"56","author":"Cubedo","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.P061598_bib38","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1016\/j.jacc.2015.04.022","article-title":"High levels of antifibrinolytic proteins are found in plasma of older octogenarians with cardiovascular disease and cognitive decline","volume":"65","author":"Cubedo","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1194\/jlr.P061598_bib39","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1476-511X-10-94","article-title":"Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART)","volume":"10","author":"Mata","year":"2011","journal-title":"Lipids Health Dis."},{"key":"10.1194\/jlr.P061598_bib40","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jacc.2016.01.008","article-title":"Attainment of LDL-cholesterol treatment goals in patients with familial hypercholesterolemia: 5-year SAFEHEART registry follow-up","volume":"67","author":"Perez de Isla","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1194\/jlr.P061598_bib41","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1373\/clinchem.2004.045203","article-title":"Reliable low-density DNA array based on allele-specific probes for detection of 118 mutations causing familial hypercholesterolemia","volume":"51","author":"Tejedor","year":"2005","journal-title":"Clin. Chem."},{"key":"10.1194\/jlr.P061598_bib42","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1373\/clinchem.2006.073957","article-title":"Comparison of DNA array platform vs DNA sequencing as genetic diagnosis tools for familial hypercholesterolemia","volume":"52","author":"Tejedor","year":"2006","journal-title":"Clin. Chem."},{"key":"10.1194\/jlr.P061598_bib43","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/jmg.37.4.272","article-title":"Universal primer quantitative fluorescent multiplex (UPQFM) PCR: a method to detect major and minor rearrangements of the low density lipoprotein receptor gene","volume":"37","author":"Heath","year":"2000","journal-title":"J. Med. Genet."},{"key":"10.1194\/jlr.P061598_bib44","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.atherosclerosis.2007.12.024","article-title":"Cardiovascular disease in familial hypercholesterolaemia: influence of low-density lipoprotein receptor mutation type and classic risk factors","volume":"200","author":"Alonso","year":"2008","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.P061598_bib45","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/clinchem\/20.4.470","article-title":"Enzymatic determination of total serum cholesterol","volume":"20","author":"Allain","year":"1974","journal-title":"Clin. Chem."},{"key":"10.1194\/jlr.P061598_bib46","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1093\/clinchem\/28.10.2077","article-title":"Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide","volume":"28","author":"Fossati","year":"1982","journal-title":"Clin. Chem."},{"key":"10.1194\/jlr.P061598_bib47","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1093\/clinchem\/29.12.2026","article-title":"Quantification of high-density-lipoprotein cholesterol by precipitation with phosphotungstic acid\/MgCl2","volume":"29","author":"Assmann","year":"1983","journal-title":"Clin. Chem."},{"key":"10.1194\/jlr.P061598_bib48","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estima\u00adtion of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin. Chem."},{"key":"10.1194\/jlr.P061598_bib49","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3109\/00365518709168939","article-title":"Immuno\u00adturbidimetric determination of apolipoproteins A-1 and B in serum","volume":"47","author":"Riepponen","year":"1987","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1194\/jlr.P061598_bib50","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1148\/radiology.148.3.6878708","article-title":"A method of comparing the areas under receiver operating characteristic curves derived from the same cases","volume":"148","author":"Hanley","year":"1983","journal-title":"Radiology."},{"key":"10.1194\/jlr.P061598_bib51","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/eurheartj\/ehu356","article-title":"Changes in thrombus composition and profilin-1 release in acute myocardial infarction","volume":"36","author":"Ramaiola","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1194\/jlr.P061598_bib52","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.amjcard.2008.08.030","article-title":"Relation of corneal arcus to cardiovascular disease (from the Framingham Heart Study data set)","volume":"103","author":"Fernandez","year":"2009","journal-title":"Am. J. Cardiol."},{"key":"10.1194\/jlr.P061598_bib53","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1093\/eurheartj\/ehn422","article-title":"Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study","volume":"29","author":"Neil","year":"2008","journal-title":"Eur. Heart J."},{"key":"10.1194\/jlr.P061598_bib54","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0009-8981(92)90108-3","article-title":"Serum apolipoproteins in heterozygous familial hypercholesterolemia","volume":"211","author":"Kajinami","year":"1992","journal-title":"Clin. Chim. Acta."},{"key":"10.1194\/jlr.P061598_bib55","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.atherosclerosis.2006.02.023","article-title":"Association of heterozygous familial hypercholesterolemia with smaller HDL particle size","volume":"190","author":"Hogue","year":"2007","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.P061598_bib56","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cccn.2005.03.050","article-title":"Altered composition of HDL3 in FH subjects causing a HDL subfraction with less atheroprotective function","volume":"359","author":"Balstad","year":"2005","journal-title":"Clin. Chim. Acta."},{"key":"10.1194\/jlr.P061598_bib57","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1172\/JCI109745","article-title":"Human apolipoprotein A-IV. Intestinal origin and distribution in plasma","volume":"65","author":"Green","year":"1980","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.P061598_bib58","doi-asserted-by":"crossref","first-page":"7859","DOI":"10.1016\/S0021-9258(19)39010-6","article-title":"Human apolipoprotein A-IV binds to apolipoprotein A-I\/A-II receptor sites and promotes cholesterol efflux from adipose cells","volume":"265","author":"Steinmetz","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.P061598_bib59","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/S0021-9258(18)89547-3","article-title":"Activation of lecithin: cholesterol acyltransferase by human apolipoprotein A-IV","volume":"260","author":"Steinmetz","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.P061598_bib60","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1161\/01.ATV.21.6.1023","article-title":"Antioxidative and antiatherosclerotic effects of human apolipoprotein A-IV in apolipoprotein E-deficient mice","volume":"21","author":"Ostos","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.P061598_bib61","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0735-1097(00)00775-0","article-title":"Low apolipoprotein A-IV plasma concentrations in men with coronary artery disease","volume":"36","author":"Kronenberg","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1194\/jlr.P061598_bib62","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1161\/01.ATV.0000119353.03690.22","article-title":"Human apolipoprotein A-IV reduces secretion of proinflammatory cytokines and atherosclerotic effects of a chronic infection mimicked by lipopolysaccharide","volume":"24","author":"Recalde","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.P061598_bib63","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nature01461","article-title":"Apolipoprotein L\u2013I is the trypanosome lytic factor of human serum","volume":"422","author":"Vanhamme","year":"2003","journal-title":"Nature."},{"key":"10.1194\/jlr.P061598_bib64","doi-asserted-by":"crossref","first-page":"21540","DOI":"10.1074\/jbc.M800214200","article-title":"Apolipoprotein L1, a novel Bcl-2 homology domain 3-only lipid-binding protein, induces autophagic cell death","volume":"283","author":"Wan","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.P061598_bib65","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0022-2275(20)33430-1","article-title":"Plasma apolipoprotein L concentrations correlate with plasma triglycerides and cholesterol levels in normolipidemic, hyperlipidemic, and diabetic subjects","volume":"41","author":"Duchateau","year":"2000","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.P061598_bib66","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/eurheartj\/ehu264","article-title":"Lipoprotein Investigators Collaborative. HDL cholesterol subclasses, myocardial infarction, and mortality in secondary prevention: the Lipoprotein Investigators Collaborative","volume":"36","author":"Martin","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1194\/jlr.P061598_bib67","doi-asserted-by":"crossref","first-page":"e000902","DOI":"10.1161\/JAHA.114.000902","article-title":"HDL-3 is a superior predictor of carotid artery disease in a case-control cohort of 1725 participants","volume":"3","author":"Kim","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"10.1194\/jlr.P061598_bib68","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/iub.588","article-title":"Coincubation of PON1, APO A1, and LCAT increases the time HDL is able to prevent LDL oxidation","volume":"64","author":"Hine","year":"2012","journal-title":"IUBMB Life."},{"key":"10.1194\/jlr.P061598_bib69","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.atherosclerosis.2011.09.052","article-title":"Accelerated subclinical coronary atherosclerosis in patients with familial hypercholesterolemia","volume":"219","author":"Neefjes","year":"2011","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.P061598_bib70","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/pmic.200401010","article-title":"Lipoproteomics II: mapping of proteins in high-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry","volume":"5","author":"Karlsson","year":"2005","journal-title":"Proteomics."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002222752035183X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002222752035183X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1194\/jlr.P061598","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T18:52:56Z","timestamp":1637434376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002222752035183X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":70,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S002222752035183X"],"URL":"https:\/\/doi.org\/10.1194\/jlr.p061598","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ApoL1 levels in high density lipoprotein and cardiovascular event presentation in patients with familial hypercholesterolemia","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1194\/jlr.P061598","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}